Synopsis
Movement Disorders Journal Podcasts 2012-2015
Episodes
-
![Common data elements for clinical research in Friedreichs ataxia]()
Common data elements for clinical research in Friedreich's ataxia
25/02/2013 Duration: 02minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Cumulative exposure to lead and cognition in persons with Parkinsons disease]()
Cumulative exposure to lead and cognition in persons with Parkinson's disease
25/02/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Rate of cognitive decline in premotor Parkinsons disease: A prospective study (NEDICES)]()
Rate of cognitive decline in premotor Parkinson's disease: A prospective study (NEDICES)
25/02/2013 Duration: 02minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Analysis of CYP2D6 genotype and response to tetrabenazine]()
Analysis of CYP2D6 genotype and response to tetrabenazine
25/02/2013 Duration: 02minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Enlarged hyperechogenic substantia nigra as a risk marker for Parkinsons disease]()
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease
25/02/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![The spectrum of cognitive disorders in Parkinsons disease: A data-driven approach]()
The spectrum of cognitive disorders in Parkinson's disease: A data-driven approach
25/02/2013 Duration: 02minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![β-amyloid in lewy body disease is related to Alzheimers disease-like atrophy]()
β-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy
25/02/2013 Duration: 02minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Brain iron deposition in essential tremor: A quantitative 3-tesla magnetic resonance imaging study]()
Brain iron deposition in essential tremor: A quantitative 3-tesla magnetic resonance imaging study
25/02/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Sonographic abnormality of the substantia nigra in melanoma patients]()
Sonographic abnormality of the substantia nigra in melanoma patients
25/02/2013 Duration: 02minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Brain dynamic neurochemical changes in dystonic patients: A magnetic resonance spectroscopy study]()
Brain dynamic neurochemical changes in dystonic patients: A magnetic resonance spectroscopy study
25/02/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Parkinsons disease duration determines effect of dopaminergic therapy on ventral striatum function]()
Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function
25/02/2013 Duration: 02minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the February 2013 (Vol. 28, Issue 2) issue.
-
![Trial Designs Used to Study Neuroprotective Therapy in Parkinsons Disease]()
Trial Designs Used to Study Neuroprotective Therapy in Parkinson's Disease
30/01/2013 Duration: 52sMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![Parkinsons Disease and Alpha Synuclein: Is Parkinsons Disease a Prion-Like Disorder?]()
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
30/01/2013 Duration: 03minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![Trophic Factor Gene Therapy for Parkinsons Disease]()
Trophic Factor Gene Therapy for Parkinson's Disease
30/01/2013 Duration: 58sMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![Pathogenesis of Parkinsons Disease]()
Pathogenesis of Parkinson's Disease
30/01/2013 Duration: 57sMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![Neuronal Vulnerability, Pathogenesis, and Parkinsons Disease]()
Neuronal Vulnerability, Pathogenesis, and Parkinson's Disease
30/01/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![New Synaptic and Molecular Targets for Neuroprotection in Parkinsons Disease]()
New Synaptic and Molecular Targets for Neuroprotection in Parkinson's Disease
30/01/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![Biomarkers for Trials of Neuroprotection in Parkinsons Disease]()
Biomarkers for Trials of Neuroprotection in Parkinson's Disease
30/01/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![Parkinsons Disease: Evidence for Environmental Risk Factors]()
Parkinson's Disease: Evidence for Environmental Risk Factors
30/01/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
-
![Animal Models of Parkinsons Disease: Limits and Relevance to Neuroprotection Studies]()
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
30/01/2013 Duration: 01minMDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the January 2013 (Vol. 28, Issue 1) issue.
